<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.moneycontrol.com/news/business/zydus-cadila-gets-usfda-nod-for-isosorbide-dinitrate-tablets-desonide-cream-4661231.html"/>
    <meta property="og:site_name" content="Moneycontrol"/>
    <meta property="article:published_time" content="2019-11-21T00:00:00+00:00"/>
    <meta property="og:title" content="Zydus Cadila gets USFDA nod for Isosorbide Dinitrate tablets, Desonide Cream"/>
    <meta property="og:description" content="The drug firm has also received final approval from US health regulator for Desonide Cream, used to treat a variety of skin conditions like eczema, dermatitis, allergies and rash, the company said in a filing to BSE."/>
  </head>
  <body>
    <article>
      <h1>Zydus Cadila gets USFDA nod for Isosorbide Dinitrate tablets, Desonide Cream</h1>
      <h2>The drug firm has also received final approval from US health regulator for Desonide Cream, used to treat a variety of skin conditions like eczema, dermatitis, allergies and rash, the company said in a filing to BSE.</h2>
      <address><time datetime="2019-11-21T00:00:00+00:00">21 Nov 2019</time> by <a rel="author">PTI</a></address>
      <p>Drug firm Zydus Cadila on Thursday said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest pain.</p>
      <p>The drug firm has also received final approval from US health regulator for Desonide Cream, used to treat a variety of skin conditions like eczema, dermatitis, allergies and rash, the company said in a filing to BSE.</p>
      <p>"Zydus Cadila has received the final approval from the USFDA to market Isosorbide Dinitrate tablets USP...in the strengths of 5 mg, 10 mg, 20 mg, 30 mg and 40 mg," the filing said.</p>
      <p>The drug is used to prevent attacks of chest pain. lt dilates blood vessels, making it easier for blood to flow through them and easier for the heart to pump.</p>
      <p>It will be manufactured at the Group's formulations manufacturing facility at Baddi, Himachal Pradesh.</p>
      <p>"The group also received the final approval for Desonide Cream (US RLD - Desonide Cream), 0.05 per cent," the filing said.</p>
      <p>The drug is a mild corticosteroid, used to treat a variety of skin conditions like eczema, dermatitis, allergies and rash, to reduce swelling, itching and redness that can occur in these types of conditions.</p>
      <p>It will be manufactured at the Group's topical manufacturing facility at Ahmedabad, it said.</p>
      <p>The shares of Cadila Healthcare, the listed entity of the group, were trading at Rs 251.35, higher by 0.92 per cent on the BSE.</p>
    </article>
  </body>
</html>